Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U7374BA | IM / LL |
Administration of expired VAXELIS; This non-serious spontaneous safety report was received by partner on 16-MAY-2025 and forwarded on 19-MAY-2025 from a medical assistant. Due to the nature of the event, the causality assessment between Vaxelis and "Administration of expired VAXELIS" is assessed as not applicable. Further information is expected. Significant follow-up information was received by the partner on 18-JUN-2025 and forwarded on 18-JUN-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality assessment between Vaxelis and "Administration of expired VAXELIS" is assessed as not applicable. Further information is not expected.
Gastroesophageal reflux; Prophylaxis; Umbilical hernia
VAXNEUVANCE; VITAMIN D [COLECALCIFEROL]; ROTATEQ; BEYFORTUS [NIRSEVIMAB]